Clinical Trial Update: Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update concerns the use of bivalirudin in patients with stable ischemic heart disease undergoing percutaneous coronary intervention,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Stable Ischemic Heart Disease

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Coronary Disease | Phase 4 | Status: UNKNOWN